Caricamento...
Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
Abstract AIM: To analyze the use of serum cancer antigen 19‐9 (CA19‐9), cancer antigen 125 (CA‐125) and carcinoembryogenic antigen (CEA) in predicting the malignant potential of mucinous ovarian tumor, and to assess the clinical factors associated with these tumors. METHODS: This retrospective study...
Salvato in:
| Pubblicato in: | J Obstet Gynaecol Res |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons Australia, Ltd
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7693209/ https://ncbi.nlm.nih.gov/pubmed/32830422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jog.14427 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|